Funder: Novo Nordisk
Due Dates: May 8, 2025 (Call opens) | August 21, 2025, 2:00pm Copenhagen time (Call closes)
Funding Amounts: DKK 6–22 million per grant (approx. 3–5 years); total grant capital DKK 89 million
Summary: Supports large-scale, non-commercial clinical trials in Denmark to advance patient care through new medicines, technologies, and rigorous research standards.
Key Information: Only non-commercial trials led by Denmark-based specialist physicians are eligible.